Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × olaparib × Gynecologic × Clear all

Status

Completed 34 Active not recruiting 25 Recruiting 21 Unknown 18 Withdrawn 6 Terminated 6 Not yet recruiting 3 No longer available 1 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

PSR Ovarian Cancer With a BRCA Mutation 1

Interventions

pegilodecakin 1 olaparib 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03063710 2018-05-17

Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan

AstraZeneca

No longer available

PSR Ovarian Cancer With a BRCA Mutation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡